The DNA changes responsible for a rare genetic condition causing babies to be born without a pancreas can now be identified ...

Labcorp joins a national CRC trial as exclusive genetic testing provider, expanding Invitae-based testing and supporting ...

Advances in genomic testing are helping doctors identify which tumours truly need chemotherapy — and which patients may do ...

A survey found that clinicians are not discussing genetic testing with 80% of patients with kidney disease who meet ...

Population-based pathogenic variant testing identified breast cancer susceptibility gene carriers who would often be missed ...

A new DNA test could spare millions of breast cancer patients from chemotherapy. We answer your questions about what it means ...

Researchers conducted a cross-sectional electronic survey to see whether respondents were offered and completed germline ...

Genetic testing can help doctors diagnose some neurological disorders, such as Huntington’s disease. It can also provide insights into a person’s risk of future health conditions. Genetic testing ...

(RTTNews) - Targeted Genomics LLC, creator of GlutenID—the first and only FDA-cleared direct-to-consumer genetic test for celiac disease—has entered a commercial partnership with OraSure Technologies, ...

The DNA changes responsible for a rare genetic condition causing babies to be born without a pancreas can now be identified in almost all affected children through genetic testing.

A groundbreaking international trial, Optima, reveals a genomic test, Prosigna, can identify breast cancer patients unlikely ...